Strides Shasun Ltd (Stride), is a vertically integrated global pharmaceutical company headquartered in Bangalore. Stride has four business verticals, viz., regulated markets, merging markets, institutional business and active pharmaceutical ingredients. Stride has a global foot prints spread across 85 countries. Shares of the company is listed on BSE and on NSE. Currently, the company has a market cap of Rs 9,100 crore (approx.)

Sequent Scientific Ltd (Sequent) is an integrated pharmaceutical company with a global footprint, operating in the domains of animal health active pharmaceuticals ingredients and formulation, human active pharmaceuticals ingredients, and analytics services. The equity shares of Sequent are listed on BSE and on NSE. Currently, it has a market cap of Rs 2,985.77 crore (approx.)

Solara Active Pharma Sciences Ltd (Solara) is a public limited company incorporated on February 23, 2017 with the objective of undertaking the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceuticals ingredients. The entire issued and paid-up share capital of Solara is held by Strides and its nominees.

Transaction Overview

The scheme provides by way of a demerger of the Commodity API business of Stride and the Human API Business of Sequent both business being B2B requires separate strategy from the other business undertaking is the major rationale behind the scheme. The appointed date is October 1, 2017 or such other date as may be decided by the NCLT

Swap Ratio

Subscribe to read the full Article.

Leave a Reply

0 Comments